ZF-screens B.V. (ZF-S)

ZF-screens B.V. (ZF-S)

Name of leader and affiliation
Dr. Ron Dirks (research manager), ZF-screens B.V. (ZF-S), Leiden, The Netherlands

ZF-screens has developed patented technology for the automated in vivo high-throughput screening of pharmaceutical drug candidates against diseases. This is achieved through novel robotic screens using model systems such as zebrafish. ZF-screens is co-owner of an Illumina HiSeq2000 sequencer and has multiple years of experience with de novo vertebrate genome assembly and mRNA-Seq analysis.



Sorry, no posts found for this author.

Consortium Partners

PreDiCT-TB brings together twenty-one leading European research partners in tuberculosis from both Industry and Academia

View More

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115337, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

The communication contained within this site reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained therein.